The Valley Desk

Clinical trial reportJournal of clinical oncology : official journal of the American Society of Clinical OncologyPublished

Durability of Response With Selpercatinib in Patients With RET-Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published
Subject terms
Humans; Carcinoma, Neuroendocrine; Thyroid Neoplasms; Anilides; Pyrazoles; Pyridines; Protein Kinase Inhibitors; Mutation; Adult; Aged; Aged, 80 and over; Middle Aged
PubMed ID
39094065
PubMed Central ID
PMC11404750
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal